G
Ganna Balagura
Researcher at University of Genoa
Publications - 26
Citations - 775
Ganna Balagura is an academic researcher from University of Genoa. The author has contributed to research in topics: Medicine & Epilepsy. The author has an hindex of 7, co-authored 17 publications receiving 191 citations. Previous affiliations of Ganna Balagura include Istituto Giannina Gaslini.
Papers
More filters
Journal ArticleDOI
The Human Phenotype Ontology in 2021
Sebastian Köhler,Michael A. Gargano,Nicolas Matentzoglu,Leigh C. Carmody,David Lewis-Smith,David Lewis-Smith,Nicole Vasilevsky,Daniel Danis,Daniel Danis,Ganna Balagura,Gareth Baynam,Gareth Baynam,Amy Brower,Tiffany J. Callahan,Christopher G. Chute,Johanna L. Est,Peter D. Galer,Shiva Ganesan,Matthias Griese,Matthias Haimel,Julia Pazmandi,Julia Pazmandi,Marc Hanauer,Nomi L. Harris,Michael Hartnett,Maximilian Hastreiter,Fabian Hauck,Yongqun He,Tim Jeske,Hugh Kearney,Gerhard Kindle,Christoph Klein,Katrin Knoflach,Roland Krause,David Lagorce,Julie A. McMurry,Jillian A. Miller,Monica Munoz-Torres,Rebecca L. Peters,Christina K Rapp,Ana Rath,Shahmir A. Rind,Avi Z. Rosenberg,Michael M. Segal,Markus G. Seidel,Damian Smedley,Tomer Talmy,Yarlalu Thomas,Samuel A. Wiafe,Julie Xian,Zafer Yüksel,Ingo Helbig,Ingo Helbig,Christopher J. Mungall,Melissa A. Haendel,Melissa A. Haendel,Peter N. Robinson +56 more
TL;DR: Recent major extensions of the Human Phenotype Ontology for neurology, nephrology, immunology, pulmonology, newborn screening, and other areas are presented and new efforts to harmonize computational definitions of phenotypic abnormalities across the HPO and multiple phenotype ontologies used for animal models of disease are presented.
Journal ArticleDOI
Epilepsy care during the COVID-19 pandemic.
J. Helen Cross,Churl-Su Kwon,Ali A. Asadi-Pooya,Ali A. Asadi-Pooya,Ganna Balagura,Patricia Gómez-Iglesias,Alla Guekht,Julie Hall,Akio Ikeda,Nirmeen A. Kishk,Peter Murphy,Najib Kissani,Yahya Naji,Emilio Perucca,Juan Carlos Pérez-Poveda,Emmanuel O Sanya,Eugen Trinka,Dong Zhou,Samuel Wiebe,Nathalie Jette +19 more
TL;DR: The International League Against Epilepsy (ILAE) COVID-19 and Telemedicine Task Forces examined, through surveys to people with epilepsy (PWE), caregivers, and health care professionals, how the pandemic has affected the well-being, care, and services for PWE as discussed by the authors.
Journal ArticleDOI
Emerging drugs for the treatment of Dravet syndrome.
TL;DR: A recent large randomized controlled trial has shown that CBD is effective in the treatment of DS; preliminary data from the placebo-controlled trial on fenfluramine are also promising and further studies are definitely required to evaluate the role of verapamil and modulators of serotonin signaling in DS.
Journal ArticleDOI
Pharmacokinetics and Drug Interaction of Antiepileptic Drugs in Children and Adolescents.
TL;DR: The mechanism of action, pharmacokinetics, drug–drug interactions, and safety/tolerability profiles of the main AEDs currently used in children and adolescents are reviewed, paying particular regard to issues of relevance when treating this patient population.
Journal ArticleDOI
Fenfluramine for the Treatment of Dravet Syndrome and Lennox-Gastaut Syndrome.
Ganna Balagura,Marta Cacciatore,Marta Cacciatore,Eleonora Grasso,Eleonora Grasso,Pasquale Striano,Alberto Verrotti +6 more
TL;DR: Fenfluramine is proving to be a promising antiepileptic drug with very favorable pharmacokinetics and with a good overall safety profile when used at a lower dosage, despite its previously link to major cardiac adverse events that prompted its withdrawal from the market in 1997.